Helix: Receives $33M in NIH funding to scale COVID-19 testing
- The U.S. National Institutes of Health (NIH) is revealing the first beneficiaries of its Rapid Acceleration of Diagnostics (RADx) program
- Helix is a health tech startup founded in 2015 that focuses on insights derived from personal genomics
- The funding will also used to support Helix’s efforts to scale its COVID-19 testing efforts
- Helix has also filed for an EUA for a second type of test, an NGS test that offers higher throughput for more testing volume
- This test, if approved, will be key to helping Helix achieve that much greater scale of testing capability
- That second test system currently seeking approval would be able to process as many as 25,000 tests per day
